Skip to content
Trial Eligibility
Menu

Autoimmune and Autoinflammatory Genetics Study

NCT06004349

This study is recruiting at 2 US sites in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

This is an exploratory natural history protocol that will enroll patients with known genetic diseases, such as VEXAS syndrome, or as yet undiagnosed disorders of inflammation with the goal of improving our understanding of disease processes. Blood, saliva, hair, nail, or buccal samples may be collected for genetic analysis, blood samples will be obtained for immunologic and other functional studies, and a small number of subjects may undergo skin biopsy.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • VEXAS Syndome
  • Autoinflammatory Disease
  • Autoimmune Disease
  • Rheumatic Disease

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
1 month and older
Sex
All
Healthy volunteers
Accepted
Sponsor
NYU Langone Health
Last updated on ClinicalTrials.gov
July 8, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New York · 2

  • NYC H+H/Bellevue · New York, NY
  • NYU Langone Health · New York, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.